Spotlight on the Ssc patient: Alice Martins Correia


news_11_Artboard 343 copy 96

Alice, without doubt, is one of the bravest pioneering patients of the global Ssc community, and whose story personalizes how devastating and aggressive this diagnosis can be, but how it can be overcome. Alice underwent a double lung transplant in 2012, and has been taking part in marathons since 2014. Warning: prepare to be in awe of Alice:

“My name is Alice, I’m 54 years old and I was born in Portugal but now I live in Geneva. In 2002 I was diagnosed with diffuse systemic sclerosis.

This illness affects the skin, as well as the heart, lungs, gastrointestinal tract, kidneys and muscles. It causes calcinosis, vascular symptoms and circulation problems such as Raynauds phenomenon.

In my personal case, it affects my skin tissues, joints, esophagus (with reflux) and my lungs with a lung disease called fibrosing type NSIP. I also had: positive antinuclear antibodies, positive SCL antibodies, positive anticardiolipin antibodies, and positive antiphospholipid antibodies.

Today I will focus specifically about my lungs. Like I said before, scleroderma seriously affected my lungs and because of that, I was taking six doses of Cyclophosphamide between November 2002 and April 2003. After April 2003 I took Aziaztriopine until May 2007.”

Read Alice Martins Correia’s full story here.

Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *